Replies to post #703054 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Nemesis18,

Your numbers are not the only thing that are off in your posts but as my calculus instructor used to say, “show me your step by step work”. Feel free to show us how Direct will be 100X current SOC cost or how treatment effect will not be worth the cost even if more than current SOC.
I am sure you already know that Direct is much simpler to make than L but will still require the same product release standards be met which is obviously why waiting on final product manufacturing processes and release under digitized procedures has been waited upon not only for L but also Direct. Best wishes.

[Love Boat Captain]

Actually, it's worth noting that during ASM Linda Powers has highlighted the incredible support and flexibility they've received from NICE. According to Powers, 'NICE has been absolutely wonderful to us. I cannot say enough wonderful things about NICE, they’ve been supportive. They’ve been flexible. They’re standing fine. You talk to them, they reach out to us every couple of months to check on the status of things. A man couldn’t imagine a government agency’s been so supportive as they have been.'

Given this strong relationship, it's certain that NICE will consider the 'vaccine' for funding. Their proactive engagement and unwavering support will pave the way for approval, despite the initial financial concerns. With such backing, NWBO will successfully navigate the approval process and secure meaningful revenue from Britain's Healthcare System.

[MasterBlastr]

You obviously ran out of things to say, as if you had any to start with.